news_image.jpg

New COVID-19 drug to be trialled in UK hospitals

24 Jun 2020



UK hospitals are trialling a new drug, TRV027, that aims to restore the balance between the two hormones, angiotensin II and angiotensin 1-7, to help prevent blood clots and lung damage caused by COVID-19.

Science Focus



Issue 48 - Summer 2020 - Thyroid disease in children

Latest Newsletter

Issue 48 - Summer 2020 - Thyroid disease in children

Issue 48 - Summer 2020 - Thyroid disease in children

Newsletter Archive

Previous newsletters can be viewed and downloaded from the archive.

Newsletter Archive